A 17-year extension on implementing intellectual property (IP) provisions that has been granted to least-developed countries (LDCs) by the World Trade Organization Council, some experts say, could allow pharma firms in Bangladesh to catch up with some of their regional rivals.
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Scrip for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?